Holding CURE?
Track your performance easily

CURE Price & Analysis

CURE ETF Chart & Stats

Direxion Daily Healthcare Bull 3x Shares (CURE) Fund Flow Chart

Direxion Daily Healthcare Bull 3x Shares (CURE) 1 year Net Flows: -43M

CURE ETF FAQ

What was CURE’s price range in the past 12 months?
CURE lowest ETF price was 75.39 and its highest was 137.56 in the past 12 months.
    What is the AUM of CURE?
    As of Aug 22, 2024 The AUM of CURE is 211.04M.
      Is CURE overvalued?
      Not enough analysts have published a price target to calculate whether the price is overvalued.
      Does CURE pay dividends?
      CURE pays a Quarterly dividend of 0.27 which represents an annual dividend yield of N/A. See more information on CURE dividends here
        How many shares outstanding does CURE have?
        Currently, no data Available
        Which hedge fund is a major shareholder of CURE?
        Currently, no hedge funds are holding shares in CURE

        Top 10 Holdings

        Name
        Weight %
        USD_CASH
        U.S. Dollar
        20.51%
        Eli Lilly And Company
        10.74%
        Unitedhealth Group Inc.
        7.52%
        Johnson & Johnson
        5.49%
        Abbvie
        4.91%
        Merck & Company
        4.15%
        Thermo Fisher Scientific
        3.29%
        Abbott Laboratories
        2.74%
        Danaher Corporation
        2.53%
        Amgen Inc
        2.50%
        Total64.39%

        ETF Description

        Direxion Daily Healthcare Bull 3x Shares

        CURE provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies.
        Sector
        Sector
        Asset Class
        Equity
        Region
        North America
        Issuer
        Direxion
        Index Tracked
        Health Care Select Sector
        Ticker Symbol
        CURE
        Popular ETFs
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis